Amplification of PVT1 contributes to the aggressive pathophysiology of ovarian and breast cancer and overexpression of PVT1 is a powerful predictor of tumor progression and overall survival in patients with diverse types of cancer, including gastric cancer [8] and colorectal cancer [12]. This evidence concerns the gene PVT1 and colorectal cancer.